Clinical Trial Update: Effect of D-cycloserine on Treatment of Posttraumatic Stress Disorder (PTSD) in Youth [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated D-cycloserine for treating posttraumatic stress disorder in youth. The study has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Tulane University School of Medicine | Conditions: Posttraumatic Stress Disorders, PTSD | Phase 2 | Status: COMPLETED | Results posted: 2017-04-21